Real investment in data science-driven innovation, despite sometimes challenging environment - Data Scientist AstraZeneca Employee Review

4.0
6 Jan 2021
Recommend
CEO approval
Business outlook

Pros

Pharma industry has been late to the digital innovation party, which means there is a lot of opportunity to drive meaningful change with automation and machine learning. AZ has also made real investment in data science-driven innovation, so tools (e.g., data science platforms) and data (internal, external) are becoming more widely available to data scientist project teams. In general, good work-life balance and great benefits.

Cons

Heavily regulated industry creates limited opportunity for rapid "test and learn" approach to creating and deploying ML models. Consensus driven culture tends to slow down decision making and innovation. Working on cross-functional teams across continents can make collaboration difficult (early Zoom calls). Finally, this is not unique to AZ, but there's always a risk that data science work can be outsourced, so political wrangling can hamper any ML project from the start.

Explore other reviews about AstraZeneca

5.0
1 July 2026
Recommend
CEO approval
Business outlook

Pros

Robust pipeline that leads to numerous job opps

Cons

Growing quickly and rapid priority changes can be confusing

4.0
5 July 2026
Recommend
CEO approval
Business outlook

Pros

Great culture, work life balance

Cons

Costly insurance, compensation not competitive

See reviews by: Helpful|Rating|Date|All